[HTML] mdpi.com

[HTML][HTML] Repetitively administered low-dose donor lymphocyte infusion for prevention of relapse after allogeneic stem cell transplantation in patients with high-risk …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - Cancers, 2021 - mdpi.com
Simple Summary Patients with high-risk acute leukemia (AL) have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). Prophylactic donor lymphocyte infusion (pro …
被引用次数：13 相关文章

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - …, 2021 - search.ebscohost.com
Abstract Simple Summary: Patients with high-risk acute leukemia (AL) have a high risk of
relapse after allogeneic stem cell transplantation (allo-SCT). Prophylactic donor lymphocyte …
[PDF] semanticscholar.org

[PDF][PDF] Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - 2021 - pdfs.semanticscholar.org
Background: Patients with high-risk acute leukemia have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate …
[PDF] academia.edu

[PDF][PDF] Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - 2021 - academia.edu
Background: Patients with high-risk acute leukemia have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate …

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute …

P Tsirigotis, K Gkirkas, V Kitsiou… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with high-risk acute leukemia have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate …

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - Cancers, 2021 - europepmc.org
Background: Patients with high-risk acute leukemia have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate …

Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High-Risk Acute …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - …, 2021 - search.proquest.com
Background: Patients with high-risk acute leukemia have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate …
[HTML] nih.gov

[HTML][HTML] Repetitively Administered Low-Dose Donor Lymphocyte Infusion for Prevention of Relapse after Allogeneic Stem Cell Transplantation in Patients with High …

P Tsirigotis, K Gkirkas, V Kitsiou, S Chondropoulos… - Cancers, 2021 - ncbi.nlm.nih.gov
Background: Patients with high-risk acute leukemia have a high risk of relapse after
allogeneic stem cell transplantation (allo-SCT). In an effort to reduce the relapse rate …